ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v17i1.2076ppharm-1808Research ArticleРЕДАКЦИОННЫЕ СТАТЬИAN EDITORIAL ARTICLEКоронавирусная инфекция у детей (состояние на февраль 2020)Coronavirus Infection in Children (Situation on February 2020)https://orcid.org/0000-0002-2209-7531Намазова-БарановаЛ. С.Namazova-BaranovaLeyla S.

Намазова-Баранова Лейла Сеймуровна - доктор медицинских наук, профессор, академик РАН, заведующая кафедрой факультетской педиатрии педиатрического факультета ФГБОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава России, руководитель НИИ педиатрии и охраны здоровья детей ЦКБ РАН Министерства науки и высшего образования РФ, научный руководитель факультета лечебного дела и педиатрии БелГНИУ, президент Союза педиатров России.

119333, Москва, ул. Фотиевой, д. 10, тел.: +7 (499) 400-47-33

Moscow, Belgorod

lsnamazova@yandex.ruhttps://orcid.org/0000-0003-3987-8112БарановА. А.BaranovAlexandr A.

Moscow

Научно-исследовательский институт педиатрии и охраны здоровья детей ЦКБ, РАН; Российский национальный исследовательский медицинский университет им. Н.И. Пирогова; Белгородский государственный национальный исследовательский университетРоссияResearch Institute of Pediatrics and Children's Health in Central Clinical Hospital; Belgorod State University; Belgorod State UniversityRussian FederationНаучно-исследовательский институт педиатрии и охраны здоровья детей ЦКБ, РАНРоссияResearch Institute of Pediatrics and Children's Health in Central Clinical HospitalRussian Federation202018042020171711Copyright © Намазова-Баранова Л.С., Баранов А.А., 20202020Намазова-Баранова Л.С., Баранов А.А.Namazova-Baranova L.S., Baranov A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/1808

Учитывая огромное количество информации в интернете об эпидемии коронавирусной инфекции, большую часть которой нельзя отнести к категории не только медицины доказательной, но хотя бы проверенной и научной, мы будем проводить анализ опубликованной литературы и представлять вам на страницах нашего журнала в каждом выпуске актуальные данные о коронавирусной инфекции в мире.

Considering the raft of information about the coronavirus infection in the Internet most of which cannot be considered not only as evidence-based medicine but even as proven or scientific, we are going to perform analysis of published literature and present you all the up-to-date data on coronavirus infection in the world in our journal in every issue.

коронавирусная инфекцияCOVID-19SARS-CoV-2диагностикаклинические проявленияпрофилактикалечениедетиcoronavirus infectionCOVID-19SARS-COV-2diagnosticsclinical signspreventionmanagementchildrenНе указанNot specifiedReferencesShen K, Yang Y. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue. World J Pediatr. 2020. [Online ahead of print] doi: 10.1007/s12519-020-00344-6.Shen K, Yang Y. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue. World J Pediatr. 2020. [Online ahead of print] doi: 10.1007/s12519-020-00344-6.Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement. World J Pediatr. 2020. [Online ahead of print]. doi: 10.1007/s12519-020-00343-7.Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement. World J Pediatr. 2020. [Online ahead of print]. doi: 10.1007/s12519-020-00343-7.Huang C, Wang Y Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.Huang C, Wang Y Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.Zhu N, Zhang D, Wang W, et al. A novel Coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi: 10.1056/NEJMoa2001017.Zhu N, Zhang D, Wang W, et al. A novel Coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi: 10.1056/NEJMoa2001017.Guan W, Ni Z, Hu Y et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. [Online ahead of print] doi: 10.1056/NEJMoa2002032.Guan W, Ni Z, Hu Y et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. [Online ahead of print] doi: 10.1056/NEJMoa2002032.Chan JF, Yuan S, Kok K, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9.Chan JF, Yuan S, Kok K, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9.Zhang J, Dong X, Cao Y et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Lancet. 2020. [Online ahead of print] doi: 10.1111/all.14238.Zhang J, Dong X, Cao Y et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Lancet. 2020. [Online ahead of print] doi: 10.1111/all.14238.Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3.Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3.WHO recommendation. Getting your workplace ready for COVID-19. 2020. Available at https://www.who.int/docs/default-source/coronaviruse/getting-workplace-ready-for-covid-19.pdf?sfvrsn=359a81e7_6.WHO recommendation. Getting your workplace ready for COVID-19. 2020. Available at https://www.who.int/docs/default-source/coronaviruse/getting-workplace-ready-for-covid-19.pdf?sfvrsn=359a81e7_6.Velthuis AJ, van den Worm SH, Sims AC, et al. Zn2+ Inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6(11):e1001176. doi: 10.1371/journal.ppat.1001176.Velthuis AJ, van den Worm SH, Sims AC, et al. Zn2+ Inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6(11):e1001176. doi: 10.1371/journal.ppat.1001176.Chang R, Sun W. Repositioning chloroquine as ideal antiviral prophylactic against COVID-19 — time is now. PrePrints. 2020. doi: 10.20944/preprints202003.0279.v1.Chang R, Sun W. Repositioning chloroquine as ideal antiviral prophylactic against COVID-19 — time is now. PrePrints. 2020. doi: 10.20944/preprints202003.0279.v1.

The authors declare that there are no conflicts of interest present.